a minimum of several months. MTX, MMF, CYC, and thalidomide are known teratogens. We strongly recommend discontinuation of these within 3 months prior to conception Data regarding timing of discontinuation are conflicting and do not permit more specific recommendations. However, discontinuation within 1 menstrual cycle would represent the minimum, and 3 months the most common, period for discontinuation. In addition to concerns about teratogenicity, it is optimal to allow adequate time for